Several inhibitors of HPRT have been identified, including allopurinol and thiopurines like 6-mercaptopurine. These compounds have shown efficacy in various preclinical models but their use in cancer therapy is limited by their side effects and the development of resistance. Ongoing research is focused on developing more selective and potent HPRT inhibitors with minimal toxicity.
